Jennings Mary Carol, Tilley Drake H, Ballard Sarah-Blythe, Villanueva Miguel, Costa Fernando Maldonado, Lopez Martha, Steinberg Hannah E, Luna C Giannina, Meza Rina, Silva Maria E, Gilman Robert H, Simons Mark P, Maves Ryan C, Cabada Miguel M
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Preventive Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Am J Trop Med Hyg. 2017 May;96(5):1097-1106. doi: 10.4269/ajtmh.16-0633. Epub 2017 Feb 6.
AbstractIn Cusco, Peru, and South America in general, there is a dearth of travelers' diarrhea (TD) data concerning the clinical features associated with enteropathogen-specific infections and destination-specific risk behaviors. Understanding these factors would allow travel medicine providers to tailor interventions to patients' risk profiles and travel destination. To characterize TD etiology, evaluate region-specific TD risk factors, and examine relationships between preventive recommendations and risk-taking behaviors among medium- to long-term travelers' from high-income countries, we conducted this case-case analysis using 7 years of prospective surveillance data from adult travelers' presenting with TD to a physician in Cusco. At the time of enrollment, participants provided a stool sample and answered survey questions about demographics, risk behaviors, and the clinical features of illness. Stool samples were tested for norovirus (NV), bacteria, and parasites using conventional methods. Data obtained were then analyzed using case-case methods. NV (14%), enterotoxigenic (11%), and (9%), notably ciprofloxacin-resistant , were the most frequently identified pathogens among adults with TD. Coinfection with multiple enteropathogens occurred in 5% of cases. NV caused severe disease relative to other TD-associated pathogens identified, confining over 90% of infected individuals to bed. Destination-specific risk factors include consumption of the local beverage "chicha," which was associated with infection. Preventive interventions, such as vaccines, directed against these pathogens could significantly reduce the burden of TD.
在秘鲁库斯科及整个南美洲,缺乏有关与肠道病原体特异性感染及目的地特异性风险行为相关的旅行者腹泻(TD)临床特征的数据。了解这些因素将使旅行医学提供者能够根据患者的风险状况和旅行目的地调整干预措施。为了确定TD的病因,评估特定地区的TD风险因素,并研究来自高收入国家的中长期旅行者中预防性建议与冒险行为之间的关系,我们利用7年来自库斯科向医生就诊的成年TD旅行者的前瞻性监测数据进行了这项病例-病例分析。在入组时,参与者提供了粪便样本,并回答了有关人口统计学、风险行为和疾病临床特征的调查问卷。粪便样本采用常规方法检测诺如病毒(NV)、细菌和寄生虫。然后使用病例-病例方法对获得的数据进行分析。在患TD的成年人中,NV(14%)、产肠毒素性(11%)和(9%),尤其是耐环丙沙星的,是最常鉴定出的病原体。5%的病例发生了多种肠道病原体的合并感染。与其他鉴定出的TD相关病原体相比,NV导致严重疾病,使90%以上的感染者卧床。特定目的地的风险因素包括饮用当地饮料“奇恰”,这与感染有关。针对这些病原体的预防性干预措施,如疫苗,可显著减轻TD的负担。